FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: referentieset voor associaties betreffende vervangende concepten (metadata)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
9093651000146111 referentieset voor associaties betreffende vervangende concepten nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
9093661000146114 referentieset voor associaties betreffende vervangende concepten (metadata) nl Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)


20431 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Recessive congenital ichthyosiform erythroderma Trichothiodystrophy (disorder)
Recomb human follicle stim horm alpha 1200iu inj pdr+diluent Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial
Recomb human follicle stim horm alpha 1200iu powder and solvent for injection solution Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial
Recombinant alpha glucosidase 50mg powder for injection solution vial Product containing only alpha-glucosidase (medicinal product)
Recombinant antihemophilic factor agent 1000 iu injection solution vial Antihemophilic factor agent only product
Recombinant antihemophilic factor agent 1000iu powder for injection solution vial Antihemophilic factor agent only product
Recombinant antihemophilic factor agent 1500 iu injection solution mL vial Antihemophilic factor agent only product
Recombinant antihemophilic factor agent 1500iu powder for injection solution vial Antihemophilic factor agent only product
Recombinant antihemophilic factor agent 2000 iu injection solution mL vial Antihemophilic factor agent only product
Recombinant antihemophilic factor agent 2000iu powder for injection solution vial Antihemophilic factor agent only product
Recombinant antihemophilic factor agent 250 iu injection solution mL vial Antihemophilic factor agent only product
Recombinant antihemophilic factor agent 250iu powder for injection solution vial Product containing precisely octocog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug)
Recombinant antihemophilic factor agent 3000 iu injection solution mL vial Antihemophilic factor agent only product
Recombinant antihemophilic factor agent 500 iu injection solution mL vial Antihemophilic factor agent only product
Recombinant antihemophilic factor agent 500iu powder for injection solution vial Product containing precisely octocog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug)
Recombinant coagulation factor IX 1000iu powder and solvent for injection solution vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 1000iu powder for conventional release solution for injection vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 1000iu powder for injection solution vial Product containing precisely nonacog alfa 1000 unit/1 vial powder for conventional release solution for injection (clinical drug)
Recombinant coagulation factor IX 250iu powder and solvent for injection solution vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 250iu powder for conventional release solution for injection vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 250iu powder for injection solution vial Product containing precisely nonacog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug)
Recombinant coagulation factor IX 500iu powder and solvent for injection solution vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 500iu powder for conventional release solution for injection vial Product containing only nonacog alfa (medicinal product)
Recombinant coagulation factor IX 500iu powder for injection solution vial Product containing precisely nonacog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug)
Recombinant coagulation factor VIIa 120,000iu powder and solvent for injection solution vial Coagulation factor VIIa only product in parenteral dose form
Recombinant coagulation factor VIIa 120,000iu powder for conventional release solution for injection vial Coagulation factor VIIa only product in parenteral dose form
Recombinant coagulation factor VIIa 240,000iu powder and solvent for injection solution vial Coagulation factor VIIa only product in parenteral dose form
Recombinant coagulation factor VIIa 240,000iu powder for conventional release solution for injection vial Coagulation factor VIIa only product in parenteral dose form
Recombinant coagulation factor VIIa 60,000iu powder and solvent for injection solution vial Coagulation factor VIIa only product in parenteral dose form
Recombinant coagulation factor VIIa 60,000iu powder for conventional release solution for injection vial Coagulation factor VIIa only product in parenteral dose form
Recombinant human follicle stimulating hormone alfa 150iu/lutropin alfa 75iu powder and solvent for injection solution vial Product containing only follitropin alfa and lutropin alfa (medicinal product)
Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon) Product containing only follitropin alfa (medicinal product)
Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon)+diluent Product containing only follitropin alfa (medicinal product)
Recombinant human follicle stimulating hormone alpha 150iu powder and solvent for injection solution ampule Follitropin alfa 300 unit/mL solution for injection
Recombinant human follicle stimulating hormone alpha 37.5iu powder for conventional release solution for injection ampule Product containing precisely follitropin alfa 37.5 unit/1 milliliter conventional release solution for injection (clinical drug)
Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon) Product containing only follitropin alfa (medicinal product)
Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon)+diluent Product containing only follitropin alfa (medicinal product)
Recombinant human follicle stimulating hormone alpha 75iu powder and solvent for injection solution ampule Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug)
Recombinant parathyroid hormone 100micrograms powder for injection solution cartridge and solvent Recombinant parathyroid hormone only product
Recombinant thrombin 20000iu powder for conventional release cutaneous solution Product containing only thrombin in cutaneous dose form (medicinal product form)
Recombinant thrombin 20000iu powder for topical solution + 20mL prefilled syringe diluent Product containing only thrombin in cutaneous dose form (medicinal product form)
Recombinant thrombin 5000iu powder for conventional release cutaneous solution Product containing only thrombin in cutaneous dose form (medicinal product form)
Recombinant thrombin 5000iu powder for topical solution + 5mL prefilled syringe diluent Product containing only thrombin in cutaneous dose form (medicinal product form)
Reconstruction of breast using distant flap of skin NEC Reconstruction of breast using distant skin flap
Reconstruction of jaw using pedicled bone flap Reconstruction of mandible using bone flap (procedure)
Reconstruction of organ NOC Reconstruction procedure
Reconstruction of urinary bladder Urinary bladder reconstruction
Recreational therapy Recreational therapy
Rectal prednisolone preparations allergy Allergy to prednisolone
Rectally given laxatives Laxative (substance)
Recurrent dislocation of other site, NEC Recurrent dislocation of joint
Recurrent hernia Herniated structure (morphologic abnormality)
Recurrent joint dislocation NOS Recurrent dislocation of joint
Recurrent joint dislocation NOS Recurrent dislocation of joint
Recurrent joint dislocation, of other specified site Recurrent dislocation of joint
Recurrent joint dislocation, of other specified site Recurrent dislocation of joint
Recurrent mouth ulcers Recurrent ulcer of mouth (disorder)
Red blood cell shape NOS Red blood cell shape
Red blood cell shape NOS Red blood cell shape
Red blood cell test Haematology test
Red color Red color (qualifier value)
Reductase Reductase
Redundant prepuce AND/OR phimosis Redundant prepuce and phimosis
Refer for imaging NOS Referral for imaging
Refer for imaging NOS Referral for imaging
Referral to microenterprise development organization Referral to microenterprise development program (procedure)
Referring organization Referring organization (observable entity)
Reflex sympathetic dystrophy of lower extremity Complex regional pain syndrome of lower limb (disorder)
Refraction or accommodation disorder NOS Disorder of refraction AND/OR accommodation
Refraction or accommodation disorder NOS Disorder of refraction AND/OR accommodation
Refractory Intractable
Refractory anaemia Myelodysplastic syndrome with low blasts (disorder)
Refractory anemia Myelodysplastic syndrome with low blasts (disorder)
Refractory anemia Myelodysplastic neoplasm with low blasts (morphologic abnormality)
Refractory anaemia with excess blasts (clinical) Subacute leukemia
Refractory anemia with excess blasts in transformation Acute myeloid leukemia with myelodysplasia-related changes (disorder)
Refractory anemia with excess of blasts Myelodysplastic syndrome with increased blasts (morphologic abnormality)
Refractory anemia with excess of blasts with transformation Acute myeloid leukemia with myelodysplasia-related changes (disorder)
Refractory anemia with excess of blasts with transformation Myelodysplastic syndrome with excess blasts (disorder)
Refractory anemia with ringed sideroblasts Myelodysplastic neoplasm with low blasts and SF3B1 mutation
Refractory anemia with ringed sideroblasts (morphologic abnormality) Myelodysplastic neoplasm with low blasts and SF3B1 mutation
Refractory anemia with sideroblasts Myelodysplastic neoplasm with low blasts and SF3B1 mutation
Refractory anemia without sideroblasts Myelodysplastic neoplasm with low blasts (morphologic abnormality)
Refractory cytopenia with unilineage dysplasia Myelodysplastic syndrome with low blasts (disorder)
Refuse procedure NOS Procedure declined (situation)
Refuse procedure NOS Procedure declined (situation)
Refused new patient screening New patient screening declined (situation)
Refused new patient screening New patient screening declined (situation)
Refused procedure - after thought Procedure declined (situation)
Refuses asthma monitoring Asthma monitoring declined (situation)
Refuses asthma monitoring Asthma monitoring declined (situation)
Refuses geriatric monitoring Geriatric monitoring declined
Refuses geriatric monitoring Geriatric monitoring declined
Refuses hormone replacement monitoring Monitoring of hormone replacement therapy declined
Refuses hormone replacement monitoring Monitoring of hormone replacement therapy declined
Refuses hypertension monitoring Hypertension monitoring declined
Refuses hypertension monitoring Hypertension monitoring declined
Refuses obesity monitoring Obesity monitoring declined
Refuses obesity monitoring Obesity monitoring declined
Refuses osteoporosis monitoring Osteoporosis monitoring declined
Refuses osteoporosis monitoring Osteoporosis monitoring declined

Start Previous Page 116 of 205 Next End


Reference Sets

Reference set descriptor

Back to Start